Skip to main content

Atrial Fibrillation clinical trials at UCSD

3 in progress, 1 open to eligible people

Showing trials for
  • Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study

    open to eligible people ages 18-100

    This is a prospective, non-randomized, multi-center, real-world post-market study to collect and evaluate data regarding the performance of the enhanced atrial fibrillation detection algorithm of the Assert-IQTM Implantable Cardiac Monitor (ICM) device.

    San Diego, California and other locations

  • Conventional Ablation With or Without Focal Impulse and Rotor Modulation to Eliminate Human AF

    Sorry, not currently recruiting here

    This prospective randomized study will assess the safety and efficacy of FIRM-guided ablation (FIRM+PVI) compared to pulmonary vein isolation (PVI) without FIRM, for the treatment of symptomatic atrial fibrillation.

    San Diego, California and other locations

  • iCLAS™ for Persistent Atrial Fibrillation

    Sorry, in progress, not accepting new patients

    Clinical study to evaluate the safety and efficacy of the Adagio AF Cryoablation System (iCLAS™) in the ablation treatment of symptomatic, persistent atrial fibrillation (PsAF). Data will be used to support a pre-market application (PMA)

    San Diego, California and other locations

Last updated: